• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia.

作者信息

Furukawa Yoshiaki, Rajput Ali H, Tong Junchao, Tomizawa Yuji, Hornykiewicz Oleh, Kish Stephen J

机构信息

From the Department of Neurology (Y.F., Y.T.), Juntendo Tokyo Koto Geriatric Medical Center, Tokyo; Department of Neurology (Y.F., Y.T.), Juntendo University Graduate School of Medicine, Tokyo, Japan; Human Brain Laboratory (Y.F., J.T., S.J.K.) and Research Imaging Centre (J.T., S.J.K.), Centre for Addiction and Mental Health, Toronto; Movement Disorders Program Saskatchewan (A.H.R.), University of Saskatchewan/Saskatoon Health Region, Canada; Center for Brain Research (O.H.), University of Vienna, Austria; Departments of Psychiatry and Pharmacology (S.J.K.), University of Toronto, Canada.

出版信息

Neurology. 2016 Sep 6;87(10):1060-1. doi: 10.1212/WNL.0000000000003065. Epub 2016 Aug 3.

DOI:10.1212/WNL.0000000000003065
PMID:27488599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5027808/
Abstract
摘要

相似文献

1
A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia.多巴反应性肌张力障碍中血清素能和多巴胺能变化之间的显著对比。
Neurology. 2016 Sep 6;87(10):1060-1. doi: 10.1212/WNL.0000000000003065. Epub 2016 Aug 3.
2
Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.帕金森病和左旋多巴诱导运动障碍中的血清素标志物。
Mov Disord. 2015 May;30(6):796-804. doi: 10.1002/mds.26144. Epub 2015 Feb 4.
3
D2 receptor binding in dopa-responsive dystonia.多巴反应性肌张力障碍中的D2受体结合
Ann Neurol. 1998 Nov;44(5):758-62. doi: 10.1002/ana.410440509.
4
Dopa-responsive dystonia: [18F]dopa positron emission tomography.多巴反应性肌张力障碍：[18F]多巴正电子发射断层扫描
Ann Neurol. 1991 Jul;30(1):24-30. doi: 10.1002/ana.410300106.
5
Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.帕金森病患者尾状核和壳核中芳香族氨基酸脱羧酶（AADC）活性的耗竭；对正在进行的腺相关病毒2型-AADC基因治疗试验的启示。
PLoS One. 2017 Feb 6;12(2):e0169965. doi: 10.1371/journal.pone.0169965. eCollection 2017.
6
Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients.三组肌张力障碍患者血浆中的多巴胺能和 5-羟色胺能改变。
Parkinsonism Relat Disord. 2021 Oct;91:48-54. doi: 10.1016/j.parkreldis.2021.08.019. Epub 2021 Sep 2.
7
Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices.
Biochem Pharmacol. 1975 Apr 15;24(8):847-52. doi: 10.1016/0006-2952(75)90152-5.
8
Intrinsic exercise capacity is related to differential monoaminergic activity in the rat forebrain.内在运动能力与大鼠前脑单胺能活性差异有关。
Brain Res Bull. 2015 Mar;112:7-13. doi: 10.1016/j.brainresbull.2015.01.006. Epub 2015 Jan 21.
9
Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.对多巴反应性肌张力障碍患者的四氢生物蝶呤（BH4）和多巴胺生物合成基因进行详尽分析。
Brain. 2009 Jul;132(Pt 7):1753-63. doi: 10.1093/brain/awp084. Epub 2009 Jun 2.
10
Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation.GCH-1 基因突变致多巴反应性肌张力障碍家系患者突触前黑质纹状体多巴胺能功能的变异性和临床异质性
J Neurol. 2018 Mar;265(3):478-485. doi: 10.1007/s00415-017-8723-5. Epub 2017 Dec 30.

引用本文的文献

1
Clinical and Basic Research on Dopa-Responsive Dystonia: Neuropathological and Neurochemical Findings.多巴反应性肌张力障碍的临床与基础研究：神经病理学与神经化学研究结果
Juntendo Med J. 2025 Jan 30;71(1):2-10. doi: 10.14789/ejmj.JMJ24-0023-R. eCollection 2025.
2
Serotonergic system in vivo with [C]DASB PET scans in GTP-cyclohydrolase deficient dopa-responsive dystonia patients.采用[C]DASB正电子发射断层扫描（PET）对GTP环化水解酶缺乏型多巴反应性肌张力障碍患者体内的5-羟色胺能系统进行研究。
Sci Rep. 2022 Apr 15;12(1):6292. doi: 10.1038/s41598-022-10067-5.

本文引用的文献

1
Dopa-responsive dystonia--clinical and genetic heterogeneity.多巴反应性肌张力障碍——临床和遗传异质性。
Nat Rev Neurol. 2015 Jul;11(7):414-24. doi: 10.1038/nrneurol.2015.86. Epub 2015 Jun 23.
2
Non-motor phenotype of dopa-responsive dystonia and quality of life assessment.多巴反应性肌张力障碍的非运动症状和生活质量评估。
Parkinsonism Relat Disord. 2014 Apr;20(4):428-31. doi: 10.1016/j.parkreldis.2013.12.014. Epub 2014 Jan 9.
3
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.帕金森病中尾状核与壳核中5-羟色胺标志物的选择性丢失。
Brain. 2008 Jan;131(Pt 1):120-31. doi: 10.1093/brain/awm239. Epub 2007 Oct 22.
4
Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice.儿茶酚胺和5-羟色胺受四氢生物蝶呤的调节方式不同。一项来自6-丙酮酰四氢蝶呤合酶基因敲除小鼠的研究。
J Biol Chem. 2001 Nov 2;276(44):41150-60. doi: 10.1074/jbc.M102237200. Epub 2001 Aug 21.
5
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia.多巴反应性肌张力障碍中纹状体生物蝶呤和酪氨酸羟化酶蛋白减少
Neurology. 1999 Sep 22;53(5):1032-41. doi: 10.1212/wnl.53.5.1032.
6
Dopa-responsive dystonia: recent advances and remaining issues to be addressed.多巴反应性肌张力障碍：最新进展及有待解决的问题
Mov Disord. 1999 Sep;14(5):709-15. doi: 10.1002/1531-8257(199909)14:5<709::aid-mds1001>3.0.co;2-t.